Tag : drug/treatment safety

Neurology

Reworked OxyContin Fails to Cut Overall Abuse, FDA Panel Says

Newsemia
After hearing the evidence, the advisory committee agreed the abuse-deterrent version of OxyContin cuts rate of snorting and injection of the drug — in one...
Latest News

What Do Early Remdesivir Data Suggest?

Newsemia
Just published data on compassionate use of the investigational drug remdesivir in hospitalized patients with severe COVID-19 suggests a benefit, but one expert says the...
Latest News

COVID-19 Daily: Remdesivir Data Published, World Leader Recovers

Newsemia
Here are the coronavirus stories Medscape’s editors around the globe think you need to know about today. Source link...
Neurology

Are FDA Panel Votes on Psych Drugs Tainted by Speakers' COIs?

Newsemia
Members of the public who receive expenses from pharmaceutical study sponsors to attend FDA advisory panel meetings to testify about new psychiatric drugs are highly...
Neurology

FDA Warns Sellers of Illegal Tianeptine Supplements

Newsemia
Jack B Goods Outlet Store and MA Labs receive warning letters from the FDA for marketing diet supplements containing the unapproved antidepressant tianeptine for opioid...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World